DHR Danaher Corporation
Danaher Corporation (DHR) trend channel, buy level and 3-month target on Trade The Path. Sector: Healthcare. Listed on NYSE. Levels below are fitted to this ticker's own swing highs and lows (Theil–Sen, log-price), then projected 3 months. On this symbol, 8 comparable calls have settled; 37.5% reached the published sell target. Information only, not financial advice.
Mid-channel, falling on both timeframes
Price is between the two trend lines. Nothing to act on yet.
Read from the last 12 months of history we hold: falling, drifting −11% a year. The target of US$210.19 is below the nearest ceiling (US$219.16), so it does not depend on a breakout. What would overturn this: a close below US$158.08 — the floor of the channel being read — after which the trend, not the entry, is what was wrong.
- 12 months read from
- US$158.02 – US$219.16 Falling channel, −11% a year
- Position in that channel
- 82% 0% at the floor, 100% at the ceiling
Price history, with the path projected 3 months forward
- Daily close
- Upper trend line (12 months)
- Lower trend line (12 months)
- Dashed after today: projected 3 months
- Our buy
- Our target
Our target
We replayed these rules over this stock's own history and the target was reached on only 3 of 8 calls. Its swings do not respect the channel reliably enough for a published call, and no alerts are sent. The numbers below are still this site's read of the fitted channel.
Buy at or below
US$198.29
level as at 16 Oct 2026
Our target
US$210.19
by 4 Nov 2026
Projected move
6.0%
gross, before costs
Price sits between our buy level and our target.
On this stock's own history these rules produced 8 settled calls, of which 3 reached target (37.5%), with an average best move of 5.6%. See the full record.
- Upper line touches
- 4
- Lower line touches
- 3
- Fit confidence
- 76%
- Fitted
- 16 Sept 2026
About Danaher Corporation
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Rainer Blair
- Employees
- 59,000
- Country
- US
Scorecard
Our own pillar scores, computed from the fundamentals below. They are not Morningstar ratings — that data is licensed and we do not redistribute it.
- Valuation
- —
- Profitability
- —
- Financial health
- —
- Cash generation
- —
Key statistics
- Market cap
- US$142.92B
- Enterprise value
- —
- Beta
- 0.81
- Avg volume
- 4.61M
- Revenue per share
- —
- Dividend yield
- —
- 52-week range
- 160.93-242.8
- Exchange
- NYSE
Key ratios
- P/E (TTM)
- —
- PEG
- —
- Price / sales
- —
- Price / book
- —
- EV / EBITDA
- —
- Gross margin
- —
- Operating margin
- —
- Net margin
- —
- Current ratio
- —
- Quick ratio
- —
- Debt / equity
- —
- Interest cover
- —
Income statement
Balance sheet
Cash flow
Trend lines are fitted statistically to past swing highs and lows and projected forward on the assumption the same rhythm continues. It often does not. This is information, not advice.